1. Nephrology: national guidelines / ed. by N.A. Mukhin. M.: GEOTAR-Media, 2009. 720 p. (series «National Guidelines»). ISBN978–5–9704–1174–2.
2. Lyusov V.A., Evsikov E. M., Teplova N. V. Etiology and factors of development and progression of severe and malignant arterial hypertension. Russian journal of cardiology. 2009; 4 (14): 6–16.
3. Sevillano ÁM, Cabrera J, Gutiérrez E, Morales E, Mérida E, Huerta A, Cavero T, Hernández E, Moreno JA, Praga M. Malignant hypertension: a type of IgA nephropathy manifestation with poor prognosis. Nefrologia. 2015; 35 (1): 42–9.
4. Zhang L, Li J, Yang S, Huang N, Zhou Q, Yang Q, Yu X. Clinicopathological features and risk factors analysis of IgA nephropathy associated with acute kidney injury. Ren Fail. 2016 Jun; 38 (5): 799–805.
5. Shaharir SS, Mustafar R, Mohd R, Mohd Said MS, Gafor HA. Persistent hypertension in lupus nephritis and the associated risk factors. Clin Rheumatol. 2015 Jan; 34 (1): 93–7.